Skip to main content

Optimize Financial Inc

SEC CIK
0002033266
Latest filing
Aug 27, 2026

CRVS holding history

Corvus Pharmaceuticals, Inc. in every 13F filed by Optimize Financial Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRVS overviewAll 13F holders of CRVSFull Q2 2026 holdings

Shares (Q2 2026)
27,963
Value
$417.8K
% of portfolio
0.2%
Quarters held
2
Since Q1 2026
Holdings of CRVS by Optimize Financial Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202627,963$417.8K0.2%−97−0.3%ReducedHolders
Q1 202628,060$410.5K0.2%+28,060NewHolders